116 related articles for article (PubMed ID: 34839935)
21. Disparities in phase 1 cancer clinical trial enrollment.
Perni S; Moy B; Nipp RD
Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
[TBL] [Abstract][Full Text] [Related]
22. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
23. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
24. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
25. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
[TBL] [Abstract][Full Text] [Related]
26. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
27. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
[TBL] [Abstract][Full Text] [Related]
29. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
[TBL] [Abstract][Full Text] [Related]
30. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
Amin S; Lucas AL; Frucht H
Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
[TBL] [Abstract][Full Text] [Related]
31. Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.
Jayakrishnan T; Nair KG; Kamath SD; Wei W; Estfan BN; Krishnamurthi SS; Khorana AA
Cancer Med; 2023 Mar; 12(6):7327-7338. PubMed ID: 36621839
[TBL] [Abstract][Full Text] [Related]
32. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.
Underwood PW; Riner AN; Neal D; Cameron ME; Yakovenko A; Reddy S; Rose JB; Hughes SJ; Trevino JG
J Surg Oncol; 2021 Dec; 124(8):1390-1401. PubMed ID: 34499741
[TBL] [Abstract][Full Text] [Related]
33. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
34. Disparities in treatment and survival between African American and White women with vaginal cancer.
Mahdi H; Kumar S; Hanna RK; Munkarah AR; Lockhart D; Morris RT; Tamimi H; Swensen RE; Doherty M
Gynecol Oncol; 2011 Jul; 122(1):38-41. PubMed ID: 21497383
[TBL] [Abstract][Full Text] [Related]
35. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.
Sineshaw HM; Ng K; Flanders WD; Brawley OW; Jemal A
Gastroenterology; 2018 Mar; 154(4):906-915.e7. PubMed ID: 29146523
[TBL] [Abstract][Full Text] [Related]
36. Regional variation in racial disparities among patients with peripheral artery disease.
O'Donnell TFX; Powell C; Deery SE; Darling JD; Hughes K; Giles KA; Wang GJ; Schermerhorn ML
J Vasc Surg; 2018 Aug; 68(2):519-526. PubMed ID: 29459014
[TBL] [Abstract][Full Text] [Related]
37. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
38. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
[TBL] [Abstract][Full Text] [Related]
39. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population.
Rauh-Hain JA; Buskwofie A; Clemmer J; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Apr; 125(4):843-851. PubMed ID: 25751197
[TBL] [Abstract][Full Text] [Related]
40. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
